# Norepinephrine in Caesarian Section

> **NCT05264870** · PHASE4 · TERMINATED · sponsor: **University Hospital, Antwerp** · enrollment: 11 (actual)

## Conditions studied

- Cesarean Section Complications
- Hemodynamic Instability
- Foetal Stress

## Interventions

- **DRUG:** Norepinephrine
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT05264870
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-09
- **Primary completion:** 2023-03-02
- **Final completion:** 2025-08-27
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** patient inclusion is too difficult
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05264870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05264870, "Norepinephrine in Caesarian Section". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05264870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*